Nonetheless, the regulatory role of Rho A/ROCK1 signaling in human CAVD models has not been elucidated, additionally the mechanisms underlying any positive effect of Rho A/ROCK1 on CAVD require further study. The gene discussed is ROCK1; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.